Close

At the BUZZ Center with Danny Bar VP General Manager, Ameridia, Division of Eurodia Industrie

David Welch, President and Senior Producer, M2 MultiMedia Communications, Inc interviews Danny Bar, VP General Manager, Ameridia, Division of Eurodia Industrie at BIO's World Congress on...

At the BUZZ Center with Paige Donnelly, Communications Manager, Novozymes North America Inc

Jack Ferguson, President of the Philadelphia Conventions Bureau (PBLCVB) interviews Paige Donnelly, Communications Manager, Novozymes North America Inc. regarding the city of Philadelphia ...

Ellen Kullman Receives the George Washington Carver Award

DuPont's CEO Ellen Kullman receives the George Washington Carver Award at BIO's 2014 World Congress on Industrial Biotechnology in Philadelphia PA. 

George Washington Carver Award remarks from Jim Greenwood

BIO's President and CEO, Jim Greenwood, gives remarks during the 2014 George Washington Carver Award at BIO's 2014 World Congress on Industrial Biotechnology in Philadelphia PA. 

Emerging Company CEOs Praise JOBS Act

Passed in 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to capital formation more attainable for small biotechnology companies, clearing the way for American innovation and ingenuity by removing bureaucratic hurdles and red tape to speed cures and medical breakthroughs to patients. In this short video, leading BIO Board Members and biotech company CEOs share the reasons why they feel the JOBS Act is critically important for today's biotech industry.

10 Governors in attendance at the 2013 BIO International Convention

Governor Dennis Daugaard, South Dakota; Governor Jay Nixon, Missouri; Governor Rick Perry, Texas; Governor Tom Corbett, Pennsylvania networking and discussing the future of biotech.

Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development

At the BIO CEO & Investor Conference in New York, BIO had the opportunity to speak with Hans Schikan, CEO of Prosensa, a company that targets rare diseases -- in particular Duchenne Muscular Dystrophy. He highlighted the important role patient advocacy organizations play in his company's drug development process and the industry's goal to help save lives and improve quality of life.

U.S. Rep. Charlie Dent Discusses the Biotech Industry's Presence in Pennsylvania

U.S. Rep. Charlie Dent discusses Pennsylvania's biotechnology industry with the Biotechnology Industry Organization's Fritz Bittenbender.

Rachel King, CEO of GlycoMimetics, Discusses Partnering and Public Policy

Mike Huckman, former CNBC anchor and Chief Strategist with Pure Communications, discuss business partnering and and public policy during the BIO CEO & Investor conference in New York

"Innovation Is..." with Ron Cohen MD, President and Chief Executive Officer, Acorda Therapeutics, Inc.

Ron Cohen MD, President and Chief Executive Officer, Acorda Therapeutics, Inc., discusses what is necessary to create an environment of biotech innovation.